Indaptus Therapeutics's total assets for Q4 2025 were $9.31M, an increase of 36.11% from the previous quarter. INDP total liabilities were $6.16M for the fiscal quarter, a 175.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.